Indication (pathologie):
Fertility agent
Identifiant SNOMED-CT:
125582005
Etudes cliniques
-
Prospective multicentre non-interventional study to assess the patterns of use of rekovelle in women undergoing in vitro fertilisation or intracytoplasmic sperm injection procedures in routine clinical practicePhase de l'étude: Phase IVRecrutement: Ouvert
-
LIBERTY 2: An international phase 3 randomized, double-blind, placebo-controlled efficacy and safety study to evaluate relugolix co administered with and without low-dose estradiol and norethindrone acetate in women with heavy menstrual bleeding associated with uterine fibroidsIndication (pathologie):Heavy menstrual bleedingIdentifiant SNOMED-CT:386692008Indication (pathologie):Uterine fibroidsIdentifiant SNOMED-CT:95315005Phase de l'étude: Phase IIIRecrutement: Ouvert
-
An international phase 3 randomized, double-blind, placebo-controlled efficacy and safety study to evaluate relugolix administered with and without low-dose estradiol and norethindrone acetate in women with endometriosis-associated painIndication (pathologie):EndometriosisIdentifiant SNOMED-CT:129103003Phase de l'étude: Phase IIRecrutement: Ouvert
-
Caractérisation des réponses d’immunité cellulaire induites par les vaccins contre la coquelucheIndication (pathologie):Whooping coughIdentifiant SNOMED-CT:27836007Recrutement: Ouvert
-
A phase 3, randomized, parallel-group, multicenter, open-label, pharmacokinetic, noninferiority study of ravulizumab administered subcutaneously versus intravenously in adult patients with paroxysmal nocturnal hemoglobinuria currently treated with eculizumabIndication (pathologie):Paroxysmal nocturnal hemoglobinuriaIdentifiant SNOMED-CT:1963002Phase de l'étude: Phase IIIRecrutement: Ouvert
-
Randomized phase 3 study evaluating the efficacy and the safety of oral azacitidine (CC-486) compared to investigator’s choice therapy in patient with relapsed or refractory angioimmunoblastic T- cell lymphomaIndication (pathologie):T-cell lymphomaIdentifiant SNOMED-CT:109978004Phase de l'étude: Phase IIIRecrutement: Ouvert
-
A phase II study of brentuximab vedotin in patients with relapsed or refractory peripheral T-cell lymphoma treated with gemcitabine followed by brentuximab vedotin maintenanceIndication (pathologie):T-cell lymphomaIdentifiant SNOMED-CT:109978004Phase de l'étude: Phase IIRecrutement: Ouvert
-
Étude contrôlée de la fragilité et de l'état physique, psychique et social des aidants proches âgésRecrutement: Ouvert
-
Étude de la qualité de vie des patients gériatriques après chirurgie programmée selon leur profil de fragilité : surgold studyIndication (pathologie):Elective surgeryIdentifiant SNOMED-CT:274075007Recrutement: Ouvert
-
Aidant proche à l’hôpital de jour gériatrique : état des lieux en Belgique francophoneRecrutement: Ouvert
-
Validation de la « geria-12 » pour détecter la présence d’une atteinte de la mémoire épisodique verbaleIndication (pathologie):Episodic memoryIdentifiant SNOMED-CT:311553000Recrutement: Ouvert
-
Prevalence and risk factors of fatigue in IBD patientsIndication (pathologie):Inflammatory bowel diseaseIdentifiant SNOMED-CT:24526004Recrutement: Ouvert
-
A prospective study to evaluate the suture pattern with the Endomina suturing device for endoscopic sleeve gastroplasty (ESG)Indication (pathologie):ObesityIdentifiant SNOMED-CT:414916001Recrutement: Ouvert
-
A phase 2 study of INCMGA00012 in participants with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapyIndication (pathologie):Anal squamous cell carcinomaIdentifiant SNOMED-CT:255084004Phase de l'étude: Phase IIRecrutement: Ouvert
-
Effects of plasma exchange with human serum albumin 5% (PE-A 5%) on short-term survival in subjects with “acute-on-chronic liver failure” (ACLF) at high risk of hospital mortalityIndication (pathologie):Acute on chronic alcoholic liver diseaseIdentifiant SNOMED-CT:713370005Phase de l'étude: Phase IIIRecrutement: Ouvert
-
A phase 1b open-label study assessing the pharmacokinetics, tolerability, and safety of oral trimetazidine in subjects with acute-on-chronic liver failure - trust: trimetazidine for acute on chronic liver failure studyIndication (pathologie):Acute on chronic alcoholic liver diseaseIdentifiant SNOMED-CT:713370005Phase de l'étude: Phase IRecrutement: Ouvert
-
REFINE: Regorafenib observational study in hepatocellular carcinomaIndication (pathologie):Hepatocellular carcinomaIdentifiant SNOMED-CT:109841003Phase de l'étude: Phase IVRecrutement: Ouvert
-
Cilostazol as imatinib synergiser in patients with unresectable or metastatic gist treated by GLIVEC®Indication (pathologie):Gastrointestinal stromal tumorIdentifiant SNOMED-CT:420120006Phase de l'étude: Phase IIRecrutement: Ouvert
-
Prodige 34-etude de phase 3 randomisée évaluant la chimiothérapie adjuvante après résection d’un adénocarcinome colique de stade 3 chez les patients de 70 ans et plus (adage)Indication (pathologie):AdenocarcinomaIdentifiant SNOMED-CT:443961001Phase de l'étude: Phase IIIRecrutement: Ouvert
-
A phase 4, double-blind, randomized, placebo-controlled study evaluating the pharmacokinetics and safety of obeticholic acid in patients with primary biliary cholangitis and moderate to severe hepatic impairmentIndication (pathologie):Primary biliary cholangitisIdentifiant SNOMED-CT:31712002Phase de l'étude: Phase IVRecrutement: Ouvert